• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.2324 -0.0286 (-10.96%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
July 07, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
July 06, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
July 02, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
July 01, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
June 30, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
June 26, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
June 25, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin
June 24, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
June 23, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit
June 22, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
June 18, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
June 17, 2026
From Cosmos Health Inc.
Via GlobeNewswire
Which stocks have an unusual volume on Wednesday? ↗
June 17, 2026
Via Chartmill
News headline image
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
June 17, 2026
From Cosmos Health Inc.
Via GlobeNewswire
Discover the most active stocks in Monday's session. ↗
June 15, 2026
Via Chartmill
News headline image
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
June 15, 2026
Company at a Turning Point — Moving the Business to a Different Level, With Growing Revenue and a Roadmap Toward Improved Profitability 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
June 12, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
June 12, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
June 11, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
June 11, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM)
June 10, 2026
Via Get News
Topics Artificial Intelligence Intellectual Property
News headline image
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
June 10, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
June 10, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
June 09, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
June 08, 2026
Strengthening proprietary IP portfolio and next-generation product development pipeline 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
June 05, 2026
Science-backed, USDA and EU-certified, whole olive tree supplement for two major wellness categories — rapidly growing global market projected to exceed $33 billion 
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
$65.3 Million Revenue in 2025 Followed by Q1 2026 Record of $17.9 Million with Momentum Continuing in Q2 for Diversified Global Heath Leader Cosmos Health Inc. (Nasdaq: COSM)
June 04, 2026
Via Get News
Topics Artificial Intelligence
News headline image
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
June 04, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
June 04, 2026
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price
June 02, 2026
From Cosmos Health Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap